The Venture Codex Logo

The Venture Codex

Epidarex Capital

7910 Woodmont Avenue, Suite 1315, Bethesda, Maryland, 20814, United States

Overview

Invests in early-stage life science and health tech companies.

Founded

2010

Deals ยท 12mo

3

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

Germany
United Kingdom
United States

Sector focus

Life Science
Venture Capital

Investment portfolio

36rounds
NAMEDATESIZE
Rouge Therapeutics
Oct 2026Participated
$58 MSeries A
Mironid
Aug 2026Participated
$46 MSeries B
RapidPulse
Jul 2026Participated
$48 MSeries B
Epsilogen
Sep 2024Participated
$16 MSeries B
Theolytics
Apr 2024Participated
$24 MOther Equity
Curve Therapeutics
Feb 2024Participated
$51 MSeries A
Enterprise Therapeutics
Jan 2024Participated
$33 MSeries B
Nyra Medical
Nov 2022Participated
$20 MSeries A
RapidPulse
Sep 2022Participated
$11 MOther Equity
Harness Therapeutics
May 2022Led
$6 MSeed
Kynos Therapeutics
Apr 2022Led
$12 MOther Equity
Epsilogen
Mar 2022Participated
$41 MSeries B
Rouge Therapeutics
Oct 2026Participated
$58 MSeries A
Mironid
Aug 2026Participated
$46 MSeries B
RapidPulse
Jul 2026Participated
$48 MSeries B
Epsilogen
Sep 2024Participated
$16 MSeries B
Theolytics
Apr 2024Participated
$24 MOther Equity
Curve Therapeutics
Feb 2024Participated
$51 MSeries A
Enterprise Therapeutics
Jan 2024Participated
$33 MSeries B
Nyra Medical
Nov 2022Participated
$20 MSeries A
RapidPulse
Sep 2022Participated
$11 MOther Equity
Harness Therapeutics
May 2022Led
$6 MSeed
Kynos Therapeutics
Apr 2022Led
$12 MOther Equity
Epsilogen
Mar 2022Participated
$41 MSeries B
36
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Epidarex Capital: 36 funding rounds are recorded in the selected participation categories.All available history.
Epidarex Capital: 36 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A107
Series B07
Series C+12
Other Equity62

Monthly Deal Activity

Epidarex Capital: 36 deals are recorded across 153 months.All available history.
Epidarex Capital: 36 deals are recorded across 153 months. All available history
MonthDeals
Feb '141
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '141
Oct '140
Nov '140
Dec '142
Jan '150
Feb '150
Mar '150
Apr '151
May '151
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '151
Dec '150
Jan '160
Feb '161
Mar '161
Apr '160
May '160
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '161
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '171
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '181
May '180
Jun '182
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '191
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '201
Oct '200
Nov '200
Dec '200
Jan '212
Feb '210
Mar '210
Apr '210
May '210
Jun '211
Jul '212
Aug '210
Sep '210
Oct '211
Nov '210
Dec '210
Jan '220
Feb '220
Mar '221
Apr '221
May '221
Jun '220
Jul '220
Aug '220
Sep '221
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '241
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '261
Sep '260
Oct '261

Sector Breakdown

Epidarex Capital: Health & Life Sciences is the largest displayed sector by deal count (36 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Epidarex Capital: Health & Life Sciences is the largest displayed sector by deal count (36 deals). All available history
SectorDeals
Health & Life Sciences36
Networks, Cloud & Communication2
Space & Frontier Tech2
Manufacturing1

Deal Size Distribution

Epidarex Capital: 36 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Epidarex Capital: 36 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M6
$5M-$10M8
$10M-$25M10
$25M-$50M9
$50M-$100M3
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Epidarex Capital: Europe has the largest recorded deal count among the displayed regions (26 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Epidarex Capital: Europe has the largest recorded deal count among the displayed regions (26 deals). All available history
RegionDeals
Europe26
United States10
Epidarex Capital: 20 co-investors are shown, with Scottish Enterprise sharing 7 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Epidarex Capital: 20 co-investors are shown, with Scottish Enterprise sharing 7 recorded deals. All available history
Co-investorShared deals
Scottish Enterprise7
British Patient Capital3
Broadview Ventures3
Hatteras Venture Partners3
IP Group3
Novartis3
Sofinnova Partners3
Syntheon3
3B Future Health Fund2
AJU IB Investment2
ALSA Ventures2
BioGeneration Ventures2
Boehringer Ingelheim2
Caribou Property2
Cormorant Asset Management2
EMBL Ventures2
Evotec2
F-Prime Capital2
Forbion2
Gimv2

Investment Strategy

Epidarex Capital: Led accounts for 50% and participating for 50% of round participation.All available history.
Epidarex Capital: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led1850%
Participating1850%
Epidarex Capital: Single-lead accounts for 56% and co-led for 44% of lead dynamics.All available history.
Epidarex Capital: Single-lead accounts for 56% and co-led for 44% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1056%
Co-led844%

Team

Elizabeth Roper

Partner

Kyparissia Sirinakis

Founder & Managing Partner

Peter Finan

Partner

Sinclair Dunlop

Managing Partner

Terri Burke

Venture Partner